N
Nathalie Massin
Researcher at University of Paris
Publications - 37
Citations - 970
Nathalie Massin is an academic researcher from University of Paris. The author has contributed to research in topics: Medicine & Infertility. The author has an hindex of 10, co-authored 23 publications receiving 831 citations.
Papers
More filters
Journal ArticleDOI
Lack of Androgen Receptor Expression in Sertoli Cells Accounts for the Absence of Anti-Mullerian Hormone Repression during Early Human Testis Development
Kahina Boukari,Geri Meduri,Sylvie Brailly-Tabard,Sylvie Brailly-Tabard,Jean Guibourdenche,Maria Luisa Ciampi,Nathalie Massin,Laetitia Martinerie,Laetitia Martinerie,Jean-Yves Picard,Rodolfo Rey,Marc Lombès,Marc Lombès,Jacques Young,Jacques Young +14 more
TL;DR: Functional ARs are essential for TT-mediated AMH repression in SC, and this finding is consistent with a failure of TT to repress AMH in the absence of AR signalling.
Journal ArticleDOI
Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique—a prospective, randomized, double-blind study
Nathalie Massin,Isabelle Cedrin-Durnerin,C. Coussieu,J. Galey-Fontaine,Jean-Philippe Wolf,Jean-Noël Hugues +5 more
TL;DR: No significant beneficial effects of androgen administration on the ovarian response to FSH could be demonstrated, however, subsequent clinical trials are needed to determine whether an optimal dose and/or a longer duration of testosterone administration may be helpful.
Journal ArticleDOI
Phenotyping and genetic studies of 357 consecutive patients presenting with premature ovarian failure
Anne Bachelot,A. Rouxel,Nathalie Massin,Jérôme Dulon,Carine Courtillot,Christine Matuchansky,Yasmina Badachi,Anne Fortin,Bernard Paniel,Fabrice Lecuru,Marie-Aude Lefrère-Belda,Elisabeth Constancis,Elisabeth Thibault,Geri Meduri,Anne Guiochon-Mantel,Micheline Misrahi,Frédérique Kuttenn,Philippe Touraine +17 more
TL;DR: A genetic cause of POF was identified in 25 patients, i.e. 7% of the whole cohort, and novel strategies of P OF phenotyping are in such content mandatory to improve the rate of PTO patients for whom etiology is identified.
Journal ArticleDOI
Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles: a prospective randomized study
Isabelle Cedrin-Durnerin,D. Grange-Dujardin,A. Laffy,I. Parneix,Nathalie Massin,J. Galey,L. Théron,Jean-Philippe Wolf,C. Conord,P. Clément,S. Jayot,Jean-Noël Hugues +11 more
TL;DR: It is shown that in an unselected group of patients, there is no evident benefit to supplement GnRH antagonist-treated cycles with rLH and the numbers of oocytes and embryos as well as the delivery rate and implantation rate were similar in both groups.
Journal ArticleDOI
New stimulation regimens: endogenous and exogenous progesterone use to block the LH surge during ovarian stimulation for IVF.
TL;DR: This review will look at the new stimulation protocols where progesterone is used to block the LH surge in ovarian stimulation, and a variety of stimulation protocols can be derived from these two methods, and their implications are discussed.